Tranexamic acid in paediatric cardiac surgery.
dc.contributor.author | Chauhan, Sandeep | en_US |
dc.contributor.author | Bisoi, Akshay | en_US |
dc.contributor.author | Modi, Rakesh | en_US |
dc.contributor.author | Gharde, Parag | en_US |
dc.contributor.author | Rajesh, M R | en_US |
dc.date.accessioned | 2003-08-19 | en_US |
dc.date.accessioned | 2009-05-27T07:21:16Z | |
dc.date.available | 2003-08-19 | en_US |
dc.date.available | 2009-05-27T07:21:16Z | |
dc.date.issued | 2003-08-19 | en_US |
dc.description.abstract | BACKGROUND & OBJECTIVES: Antifibrinolytic agents are used commonly in adult cardiac surgery to reduce postoperative blood loss. Paucity of literature on the use of a newer antifibrinolytic agent tranexamic acid (TA) in children undergoing cardiac surgery promoted us to conduct this study in children with cyanotic heart disease. METHODS: One hundred and twenty consecutive children with cyanotic heart disease were randomised into two groups. Control (group A) (n=24) given no drug while the study (group B, n=96) group was given tranexamic acid 10 mg/kg each after anaesthetic induction, on bypass and after protamine at the end of bypass. Postoperatively, total mediastinal chest tube drainage and blood and blood product usage at 24 h were recorded. Tests of coagulation including activated clotting time, fibrinogen, fibrin degradation products and platelet count were performed at 6 h postoperatively. RESULTS: The two groups were comparable in terms of demographic characteristics such as age, sex, weight, operations performed, and preoperative haematocrit. Postoperatively, group B, had a significantly (P<0.05) lower blood loss, blood and blood product usage, re-exploration rate compared to the control group. There was preservation of fibrinogen and lower levels of fibrin degradation products in group B. INTERPRETATION & CONCLUSION: Tranexamine acid was highly effective in reducing post-operative blood loss, blood and blood product usage in children with congenital cyanotic heart disease undergoing corrective surgery. | en_US |
dc.description.affiliation | Department of Cardiac Anaesthesia, Cardiothoracic Centre, All India Institute of Medical Sciences Ansari Nagar, New Delhi, India. sdeep61@yahoo.com | en_US |
dc.identifier.citation | Chauhan S, Bisoi A, Modi R, Gharde P, Rajesh MR. Tranexamic acid in paediatric cardiac surgery. Indian Journal of Medical Research. 2003 Aug; 118(): 86-9 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/20362 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://icmr.nic.in/ijmr/ijmr.htm | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Antifibrinolytic Agents --therapeutic use | en_US |
dc.subject.mesh | Cardiac Surgical Procedures | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child, Preschool | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Pediatrics | en_US |
dc.subject.mesh | Prospective Studies | en_US |
dc.subject.mesh | Tranexamic Acid --therapeutic use | en_US |
dc.title | Tranexamic acid in paediatric cardiac surgery. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Journal Article | en_US |
dc.type | Randomized Controlled Trial | en_US |
Files
License bundle
1 - 1 of 1